U.S. Markets closed

Albany Molecular Research, Inc. (AMRI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.82+0.14 (+0.79%)
At close: 4:00PM EDT

17.77 -0.05 (-0.26%)
After hours: 4:17PM EDT

People also watch
ARQLARRYALKSENZNANIK
Interactive chart
Previous Close17.68
Open17.66
Bid15.60 x 2500
Ask18.38 x 900
Day's Range17.44 - 17.99
52 Week Range12.51 - 19.35
Volume555,066
Avg. Volume766,840
Market Cap742.7M
Beta0.70
PE Ratio (TTM)-10.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents11 days ago

    Edited Transcript of AMRI earnings conference call or presentation 9-May-17 12:30pm GMT

    Q1 2017 Albany Molecular Research Inc Earnings Call

  • Associated Press15 days ago

    Albany Molecular Research posts 1Q loss

    The Albany, New York-based company said it had a loss of 25 cents per share. Earnings, adjusted for one-time gains and costs, came to 13 cents per share. The results beat Wall Street expectations. The ...

  • American City Business Journals28 days ago

    Report: AMRI considering $1 billion sale

    Drug manufacturer Albany Molecular Research Inc. is looking at a $1 billion sale, according to Bloomberg News. AMRI is working with Credit Suisse Group AG to explore a sale, Bloomberg reports, citing unidentified sources. Carlyle Group LP and Pamplona Capital Management, two private equity firms with records of investing in pharmaceutical and health care deals, have expressed interest.